INDEMNITY AGREEMENTIndemnity Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of _____________, 2020, is made by and between Humanigen, Inc., a Delaware corporation (the “Company”), and [Name of Individual] (“Indemnitee”).
ContractEmployment Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (“Agreement”), is dated as of August 1, 2020 (the “Effective Date”), by and between Humanigen, Inc., a Delaware corporation with offices at 533 Airport Blvd, Suite 400, Burlingame, CA 94010 (the “Corporation”), and Timothy E. Morris, an individual (“Executive”). The Parties to this Agreement are the Corporation and Executive, referred to individually as the “Party.”
ContractAmended and Restated Employment Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”), is dated as of October 29, 2020 (the “Effective Date”), by and between Humanigen, Inc., a Delaware corporation with its principal office at 533 Airport Blvd, Suite 400, Burlingame, CA 94010 (the “Corporation”), and Dr. Cameron Durrant, an individual (“Executive”). The Parties to this Agreement are the Corporation and Executive, referred to individually as the “Party.” This Agreement amends and restates that certain Employment Agreement dated as of July 1, 2016, by and between the Executive and the Corporation (the “Prior Agreement”), so that upon the effectiveness of this Agreement, the Prior Agreement shall be of no further force and effect, and shall be superseded and replaced in its entirety by this Agreement.
ContractEmployment Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • California
EMPLOYMENT AGREEMENT (“Agreement”), as of July 6, 2020, by and between Humanigen, Inc., a Delaware corporation with offices at 533 Airport Blvd, Suite 400, Burlingame, CA 94010 (the “Corporation”), and David L. Tousley, an individual (“Executive”).
CERTAIN IDENTIFIED INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY, IF PUBLICLY DISCLOSED. LENZILUMAB LICENSE AGREEMENT AMONG HUMANIGEN,...License Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • New York
TELCON RF PHARMACEUTICAL, INC., a South Korean corporation (KOSDAQ: 200230) with offices at 54, Gongse-ro, Giheung-gu, 17086, South Korea (“Telcon”).
MASTER CONSULTING AGREEMENTMaster Consulting Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations • North Carolina
This agreement (“Agreement”) is made on March 6, 2021 (“Effective Date”), by and between David Tousley, doing business as Stratium Consulting Services (“Consultant”), and Humanigen, Inc., a Delaware corporation, whose mailing address is 533 Airport Boulevard, Suite 400, Burlingame, CA 94010 (“Client”). Consultant offers general business consulting services to Client relating to Client’s company. Client wishes to engage Consultant, from time to time, to perform general business consulting services in connection with Client’s company.
A COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTA Cooperative Research and Development Agreement • March 10th, 2021 • Humanigen, Inc • Pharmaceutical preparations
